Edwards Lifesciences (EW) news
Recent news
ESG stocks rose in regular trading, with West Pharmaceutical Services up 2.5%, Trimble gaining 2.3% and Edwards Lifesciences rising 2.3%.
On October 5, 2026, ESG-focused stocks saw gains in regular trading, reflecting continued investor interest in sustainability-oriented equities. West Pharmaceutical Services (WPH) rose 2.5%, Trimble (TRMB) advanced 2.3%, and Edwards Lifesciences (EW) climbed 2.3%. These movements align with broader…
AInvest Wire · Oct 5, 2026Zimmer, Sight Sciences, Edwards get upside catalyst watch: Citi
Citi analysts have highlighted Zimmer Biomet, Sight Sciences, and Edwards Lifesciences as companies poised for potential upside catalysts in the near term, according to recent market commentary. The firm’s assessment is based on anticipated developments in regulatory approvals, product launches,…
AInvest Wire · Oct 5, 2026MTR Corp - Expects to recognise HSR settlement sum as an expense in FY26
MTR Corporation has indicated that it expects to recognise the $250 million Hart-Scott-Rodino (HSR) settlement sum as an expense in its fiscal year 2026 (FY26) financial statements. The settlement, which involves KKR & Co. Inc., was proposed by the U.S. Department of Justice (DOJ) on August 26,…
AInvest Wire · Oct 2, 2026Edwards Lifesciences gets FDA approval for Autus valve, first surgical pulmonary valve for pediatric patients
Edwards Lifesciences has received U.S. Food and Drug Administration (FDA) approval for the Autus valve, marking it as the first surgical pulmonary valve specifically designed for pediatric patients. This development represents a significant advancement in the treatment of congenital heart defects,…
AInvest Wire · Oct 1, 2026FDA OKs Edwards Lifesciences' Autus size-adjustable heart valve
Edwards Lifesciences has received regulatory approval for the Autus size-adjustable heart valve, marking a significant advancement in pediatric cardiology. The device is designed for surgical pulmonary valve replacement in patients aged 18 months to 16 years. A key feature of the Autus valve is its…
AInvest Wire · Oct 1, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.